da Luca Bonadei | Mag 7, 2021 | Altro
https://www.ema.europa.eu EMA: Comitato per le Terapie Avanzate (CAT) Verbale della riunione del 17 – 19 febbraio 2021
da Luca Bonadei | Mag 7, 2021 | Other
https://www.ema.europa.eu EMA: Committee for Advanced Therapies (CAT) Minutes of the meeting on 17 – 19 february 2021
da Luca Bonadei | Mag 7, 2021 | Regulatory
https://www.pharmastar.it Janssen announced that it has applied for marketing authorization to EMA for CAR-T therapy, for the treatment of patients with relapsed/refractory multiple myeloma. This is an experimental therapy with ciltacabtagene autoleucel (cilta-cel)...
da Luca Bonadei | Mag 7, 2021 | Regolatorio
https://www.pharmastar.it Janssen ha annunciato di aver presentato all’EMA la richiesta di autorizzazione all’immissione in commercio della terapia CAR-T, per il trattamento di pazienti con mieloma multiplo recidivato refrattario. Si tratta di una terapia sperimentale...
da Luca Bonadei | Apr 7, 2021 | Business
https://www.pharmastar.it Novartis has added to its pipeline two kinds of radioagents from iTheranostics, FAPI-46 and FAPI-74. These two radioactive drugs target fibroblast activation proteins (FAP) that are expressed on the surface of tumors cells. FAP are...